Meta Platforms (META: NASDAQ)

Meta Platforms (META) is a social media and internet content company. Recently, Meta released its latest AI model, Llama 3.1, which outperforms the latest GPT-4o on multiple benchmarks. Llama 3.1 is open-source, encouraging developer engagement and continuous improvement over time. Meta plans to integrate this AI into its applications and virtual reality headsets, expanding its influence across its vast user base.

Meta’s business has become more efficient through AI, particularly in its Reels recommendation algorithm on Facebook and Instagram. The enhanced user engagement makes Meta’s platforms more attractive to advertisers.

Additionally, Meta announced the introduction of a quarterly dividend, boosting its appeal to dividend investors while maintaining positive long-term growth prospects.

We are bullish on META above $450.00-$455.00, with an upside target of $690.00-$700.00.

Sanofi (SNY: NASDAQ)

Sanofi (SNY), a $134 billion pharmaceutical giant based in Paris, France, is heavily engaged in research, development, manufacturing, and marketing of specialty care treatments for neurological and immunological diseases, as well as rare blood disorders. The company also focuses on drugs for diabetes and cardiovascular diseases. With a dividend yield of 3.8%, Sanofi currently offers more than double the average yield of S&P 500 companies.

Sanofi’s broad pharmaceutical portfolio provides the company with a stable foundation, and its strong track record of successfully bringing drugs to market demonstrates its potential for future growth. The company also has a promising pipeline of new drugs in development, which adds further upside potential for investors. This stability and growth opportunity make Sanofi an attractive investment in the biotech industry.

It’s no surprise that Warren Buffett’s Berkshire Hathaway has held shares in Sanofi since 2006, with Buffett buying more shares at least 10 additional times. For investors looking for a safer path to profit from the biotech boom, Sanofi offers a solid option, delivering both growth potential and a hefty dividend payout.

Ethereum (ETHUSDT)

ETH’s daily chart remains unchanged, as the price continues to consolidate within its current range. The longer this consolidation persists, the larger the anticipated breakout could be. We are currently positioned long, but traders should remain cautious of a potential stop-hunt that could trigger a flush to the downside before a significant move occurs. The $2,350 support level stands out as a key area to watch if such a flush happens.

The Graph (GRTUSDT)

The price of GRT is currently breaking out above the top of the range support level, signaling a potential long position opportunity. Enter a trade between $0.16 and $0.15, with take profit targets at $0.20 and $0.247. Set your stop loss to trigger on a close below $0.1445 to manage risk effectively.